Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Shih

Showing results (601-610 of 615) with videos related to

Pageof 62
Sort By:
Nature Genetics|March 24, 2020
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinomaDavid J H Shih, Naema Nayyar, Ivanna Bihun, et al.
Cell|February 24, 2018
A Hematogenous Route for Medulloblastoma Leptomeningeal MetastasesLivia Garzia, Noriyuki Kijima, A Sorana Morrissy, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Nature|July 22, 2014
Enhancer hijacking activates GFI1 family oncogenes in medulloblastomaPaul A Northcott, Catherine Lee, Thomas Zichner, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Respiratory Medicine|April 3, 2024
Benralizumab efficacy and safety in severe asthma: A randomized trial in AsiaKefang Lai, Dejun Sun, Ranran Dai, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Nature|February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyS C Mack, H Witt, R M Piro, et al.
Pageof 62

Showing results (601-610 of 615) with videos related to

Sort By:
Pageof 62
Nature Genetics|March 24, 2020
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinomaDavid J H Shih, Naema Nayyar, Ivanna Bihun, et al.
Cell|February 24, 2018
A Hematogenous Route for Medulloblastoma Leptomeningeal MetastasesLivia Garzia, Noriyuki Kijima, A Sorana Morrissy, et al.
Acta Neuropathologica|July 19, 2018
Heterogeneity within the PF-EPN-B ependymoma subgroupFlorence M G Cavalli, Jens-Martin Hübner, Tanvi Sharma, et al.
Acta Neuropathologica Communications|December 26, 2014
WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Nature|July 22, 2014
Enhancer hijacking activates GFI1 family oncogenes in medulloblastomaPaul A Northcott, Catherine Lee, Thomas Zichner, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Respiratory Medicine|April 3, 2024
Benralizumab efficacy and safety in severe asthma: A randomized trial in AsiaKefang Lai, Dejun Sun, Ranran Dai, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Nature|February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyS C Mack, H Witt, R M Piro, et al.
Pageof 62